Not exact matches
As the team reports today in Science Translational Medicine, no one developed
malaria or suffered serious harm in this
first phase of human tests, and the
vaccine triggered antibodies
against the sporozoites.
An experimental
vaccine poised to win World Health Organization approval as the
first to even partially protect children
against malaria works better
against one strain of the disease - causing parasite than others.
The coming year will see the widespread testing of the
first effective
vaccine against Plasmodium falciparum, the parasite that causes the most deadly type of
malaria.